key: cord-0820700-w1fzkr6t
authors: Winter, Daniella; Braw, Yoram
title: COVID-19: Impact of Diagnosis Threat and Suggestibility on Subjective Cognitive Complaints
date: 2021-05-24
journal: Int J Clin Health Psychol
DOI: 10.1016/j.ijchp.2021.100253
sha: 320398e06789bdb734c3bd6f035c21601d564a1d
doc_id: 820700
cord_uid: w1fzkr6t

BACKGROUND/OBJECTIVE: A subset of recovered COVID-19 patients report persistent neurological symptoms. These include non-specific symptoms (e.g., headaches and fatigue) which were found to be affected by psychological processes in other disorders (e.g., post-concussion syndrome, PCS, after mild traumatic brain injury). The current study assessed the impact of diagnosis threat (i.e., information regarding the long-term neurological impact of COVID-19) and suggestibility on endorsed symptoms of both recovered patients and healthy controls. METHOD: Recovered patients (n = 90) and healthy controls (n = 210) described their cognitive functioning after being randomly assigned to: (a) Experimental group: These participants read an article that explored long-term neurological symptoms among COVID-19 survivors. (b) Control group: These participants read an article providing general information regarding the disease. RESULTS: Recovered patients, but not healthy controls, endorsed more symptoms in the experimental condition compared to the control condition. Moreover, suggestibility was correlated with endorsement of symptoms. CONCLUSIONS: Post COVID-19 neurological symptoms may, at least partially, be affected by non-neurological factors such as diagnosis threat. Information regarding long-term effects of COVID-19 may skew reported symptoms with highly suggestible individuals particularly susceptible to these effects. Further research, however, is needed to validate and elaborate upon these initial findings.

5 Therefore, we randomized recovered COVID-19 patients and healthy controls to either diagnosis threat condition (i.e., participants received information regarding the neurological symptoms associated with PCNS) or control condition (i.e., participants received general information regarding as part of the current study. They then reported symptoms of cognitive dysfunction. As well as manipulating diagnosis threat, we also assessed the participants' suggestibility.

The latter is defined as a communication process resulting in the acceptance of a proposition despite the absence of logically adequate grounds for its acceptance (Gudjonsson, 1987) . Importantly, suggestibility may be a key factor in explaining the effect of diagnosis threat. For example, highly suggestible participants experienced a greater decrease in performance following instructions that likely activated diagnosis threat (Carter-Allison et al., 2016) . Relatedly, these individuals may be especially prone to report higher levels of cognitive dysfunction, particularly in contexts that reinforce their beliefs in these impairments (Delis & Wetter, 2007) . We hypothesized that: (a) Participants, particularly recovered COVID-19 patients, will report greater cognitive dysfunction in the diagnosis threat condition compared to the control condition. (b) Suggestibility will be significantly correlated with reported cognitive dysfunction. (c) Suggestibility will moderate the relationship between diagnosis threat and reported cognitive dysfunction.

Adult (i.e., ≥ 18 years old) native Hebrew speakers participated in the study (N = 337). The participants were recruited via social media forums devoted to COVID-Diagnosis threat and post COVID-19 cognitive complaints 6 6 19 and through Ariel University's experimental bulletin board. The latter were undergraduate students who received course credit for participating in the study.

Those who were still ill were excluded (n = 13) and data of 24 additional participants who did not complete the survey or responded incorrectly to the manipulation check (see procedure subsection) were not analyzed (final N = 300, n = 90 recovered patients, n = 210 healthy controls). See CONSORT diagram (Fig. 1 ). *** INSERT FIGURE 1 HERE ***

Cognitive failures questionnaire (CFQ): A self-report scale that ranks cognitive failures in daily life, such as attention lapses and memory problems (Broadbent et al., 1982; Wilhelm et al., 2010) . It consists of 25 items which indicate how often the participant noted a certain problem, with scores ranging from 0 ("never") to 4 ("very often"). Total score served as its outcome measure (0-100). The CFQ has good internal consistency (internal consistency coefficient, ICC = . 89; Broadbent et al., 1982) and test-retest reliability (Bridger et al., 2013) . Correspondingly, Cronbach's α in the current study was .92. Regarding validity, the CFQ is significantly correlated with other measures of subjective cognitive complaints (e.g., r = .62 with Reason's absent-mindedness questionnaire; Broadbent et al., 1982) and was described as a validated measure of real-world daily cognitive lapses which provides wider coverage than similar measures (Carrigan & Barkus, 2016 Kotov et al., 2004) . Its items are related to consumer and psychological suggestibility, persuasiveness, peer conformity, and physiological reactivity (e.g., "I get a lot of good practical advice from magazines or TV"). Each item is rated from 1 ("not at all or very slightly") to 5 ("a lot"). Total score served as the outcome measure (21-105). The scale had high internal reliability (rs = .86-.89) and was deemed reliable based on two different samples (n = 712 and n = 638; Kotov et al., 2004) . Correspondingly, Cronbach's α in the current study was .91. The SSS is strongly correlated with the MISS (Kotov et al., 2004; Nitzan et al., 2015) and shows the expected associations with relevant variables among both healthy participants and clinical populations (e.g., overweight and obesity; Ray et al., 2020) .

The study was conducted using the Qualtrics survey software (for a related study using the platform, see Nelson et al., 2020) . Participants provided general demographic data. They were then requested to read an article and were notified that they will be later questioned regarding its content (i.e., a manipulation check).

Afterwards, the participants were randomly assigned to one of two conditions, regardless of their current COVID-19 status (recovered patients vs. healthy and were based on recent publications (e.g., Menni et al., 2020) . The study was approved by the Institutional Review Board (IRB) committee with all participants consenting to participate in the study.

(PCNS article or control article) and group (recovered COVID-19 patients or controls) was performed on cognitive complaints (CFQ total score). It indicated significant group and diagnosis threat main effects which were qualified by a significant group x diagnosis threat interaction [F(1,296) = 4.68, p = .031, η 2 p = 0.16, 95% CI [0.80, 8.29]; F(1,296) = 4.69, p = .031, η 2 p = 0.14, 95% CI [0.06, 7.55];

F(1,296) = 4.93, p = .027, η 2 p = 0.17, 95% CI [60.93, 64.80]; respectively]. Among recovered COVID-19 patients, those in the diagnosis threat condition reported a larger cognitive impairment than those in the control condition, t(86) = -2.46, p = .016, d = 0.52, 95% CI [-16.40, -1.15 ]. In contrast, this difference was not significant among healthy controls, t(206) = 0.07, p = .939. See Figure 2 . As the recovered COVID-19 patients and healthy controls differed in several variables (see Table 1 ), 9 the analysis was repeated using these variables as covariates, either grouped together or in separate analyses. The findings of these analyses were like those of the original analyses and are therefore not presented. *** INSERT FIGURE 2 HERE *** *** INSERT TABLE 1 HERE *** A Pearson product-moment correlation analysis between the extent of cognitive complaints (CFQ total score) and suggestibility (SSS total score) revealed a significant positive correlation, r = .40, p < .001. Hayes' PROCESS module for SPSS (Hayes, 2018) was performed for each of 5000 bootstrapped samples. The combined effect of diagnosis threat and suggestibility on cognitive complaints (CFQ total score) was significant (R 2 = .18, r = .42, F(3,296) = 21.67, p < .001). Diagnosis threat in isolation from suggestibility was not a significant predictor (b = 1.83, t = 1.12, p = .261). Suggestibility, however, in isolation from diagnosis threat remained significantly correlated with cognitive complaints (b = 0.32, t = 3.52, p < .001, 95% CI [0.14, 0.50]). The interaction was also significant, indicating that suggestibility moderates the effect of diagnosis threat on the participants' cognitive complaints (R 2 = .01, b = 0.29, t = 2.33, p = .02, 95% CI [0.04, 0.55]). Diagnosis threat was associated with the extent cognitive complaints (i.e., CFQ total scores) among highly suggestible individuals (CFQ total score = 68.00 ± 0.13; b = 5.64, SE = 2.31, p = .015, 95% CI [1.08, 10.19]). In contrast, the effect was not significant among those with average (CFQ total score = 61.92 ± 0.09; b = 1.83, SE = 1.62, p = .261) or 10 low suggestibility levels (CFQ total score = 55.84 ± 0.13; b = -1.97, SE = 2.30, p = .391). See figure 3. *** INSERT FIGURE 3 HERE ***

Though not in the focus of the current study, we examined the contribution of the following demographic and disease-related variables: (a) Age: Pearson product-moment correlation analysis between suggestibility (SSS total score) and age revealed a significant inverse correlation, r = -.36, p < .001 (i.e., older participants tended to be less suggestible). However, entering age as a covariate in the analyses did not meaningfully alter the study's findings (not presented). (b)

Gender: An independent-samples t-test revealed that women reported more cognitive impairment than men, t(298) = -3.27, p < .001, d = 0.41, 95% CI [-10.40, -2.42 ]. Note, however, that the groups did not differ significantly in gender distribution and entering gender as an independent variable in the analyses did not alter the study's findings (not presented). (c) Duration of COVID-19 disease:

Suggestibility (SSS total score) and duration of COVID-19 disease were not significantly correlated (r = -.09, p = .401). Correspondingly, use of disease duration as a covariate did not alter the study's findings (not presented).

Finally, cognitive complaints (CFQ total score) were analyzed using analysis of variance (ANOVA) with between-subjects factors of gender, education level (≤12 years, 13-15 years, ≥16 years) and suggestibility (low, average, and high; i.e., the sample was divided according to participants' SSS total scores). The analysis 11 revealed no significant gender, education level, or suggestibility main effects 

Analyses were conducted using the IBM Statistical Package for Social Sciences (SPSS) version 26.0 with a two-tailed p < .05 considered statistically significant in all analyses. Variables were assumed to be normally distributed after examining histograms (in accordance with Ghasemi & Zahediasl, 2012 ).

The current study contributes to the literature on diagnosis threat and suggestibility by focusing on the current COVID-19 pandemic. As expected, recovered COVID-19 patients reported more cognitive dysfunction than healthy controls, corresponding to recent studies (Goërtz et al., 2020) . The study's key finding, however, was the effect of diagnosis threat; exposure to information regarding PCNS increased self-reported symptoms of cognitive dysfunction, but only among recovered COVID-19 patients. Diagnosis threat appears to be a specific manifestation of negative response expectancies (Kirsch, 1999) , overlapping with the nocebo effect. The latter refers to the effects of negative expectations or anticipated future outcomes on state of health, with studies repeatedly indicating 12 its widespread impact (Colloca & Barsky, 2020) . Though speculative at present, the effect may stem from priming of memories related to everyday cognitive lapses, common in the general population (Voormolen et al., 2019) . This possibility is in line with the expectation as etiology theory according to which PCS results from the linking of everyday complaints to a previous injury (i.e., a concussion) and thereby fueling expectations about recovery (Broshek et al., 2015) . Furthermore, the current study implicates suggestibility in the susceptibility to the impact of diagnosis threat (Carter-Allison et al., 2016) . More specifically, highly suggestible recovered COVID-19 patients were found to be particularly prone to the effects of diagnosis threat in their reporting of cognitive dysfunction. Self-reports of everyday cognitive functioning, a key element in the medical interview, may therefore be prone to the effect of diagnosis threat and related non-neurological factors (e.g., clinician driven iatrogenic processes; Niesten et al., 2020) .

Limitations of the current study include: (a) COVID-19 patients were mostly recruited through social media forums devoted to the disease. Therefore, the sample may not be representative of the general COVID-19 recovering patient population (e.g., participants in the current study may be more anxious or experience more symptoms). (b) The study included undergraduate students which were mostly healthy, likely contributing to baseline differences between the recovered COVID-19 patients and healthy controls. Readers are therefore advised to focus on the comparisons between the patient groups (diagnosis threat vs. control condition) which represent a more rigorous research design (i.e., randomized controlled trial). (c) As noted by an anonymous reviewer, additional variables that may have impacted the findings were not assessed. For example, Diagnosis threat and post COVID-19 cognitive complaints 13 13 disease duration and its consequences, psychological variables (e.g., affective symptoms and patient resilience which was recently suggested as predictor of adaptive response to the COVID-19 pandemic and lockdown; Kocjan, 2021) and environmental factors (e.g., exposure to stress significantly increases suggestibility; Morgan III et al., 2020) . Since the current study was constructed as a preliminary investigation, these variables -apart from disease duration which likely did not impact the findings -were not assessed. Consequently, it is advisable to include them in future studies.

The findings of the current study should be viewed as preliminary and await validation. Researchers are encouraged to include non-recovered patients and increase the sample size to enable more elaborate analyses and exploration of relevant variables. The effects of neuropathology on self-reported cognitive functioning, a link that was suggested in recent studies (Sun et al., 2021) , is in this regard an important path that researchers can follow. This is in line with studies linking subjective cognitive complaints to neurological biomarkers (Cantero et al., 2016; Liang et al., 2020; Llado-Saz et al., 2015) . Researchers are also encouraged to assess whether cognitive complaints are manifested in objective tests and real-life functioning, as well as explore recovered COVID-19 patients' mental health during the disease and after recovery (Bueno-Notivol, 2021), including variables that predict resilience in unusual circumstances (e.g., positive mental health; Brailovskaia, 2020). Relatedly, misinformation regarding COVID-19 has been the focus of increased concern (Merckelbach et al., 2018; Pennycook et al., 2020) .

Individuals may not accurately distinguish between scientific and pseudoscientific information, leading to serious medical complications (Pulido, 2020) , which 14 stresses the need to further research. Exploration of demographic variables is also of importance. For example, age was correlated with suggestibility in the current study. Similarly, older adults show greater reduction in suggestibility when exposed to misleading information compared to younger adults (Huff & Umanath, 2018) . Additionally, females reported more cognitive impairment than males in the current study, similar to earlier findings regarding general symptom endorsement in the context of COVID-19 (Fiorenzato et al., 2021) . This likely did not confound the current study's conclusions, as the use of age as a covariate in the analyses did not alter the study's findings. Correspondingly, the groups did not differ significantly in gender distribution and gender did not alter the findings when entered as an independent variable. Nevertheless, this stresses the need for further research of these key demographic variables. Concepts related to suggestibility may also be the focus of research. For example, the 'being a patient effect' refers to the influence of group membership (i.e., knowledge that they are patients) on self-perception and cognitive functioning (Schwarz et al., 2018) and it would be of interest to investigate it with regard to COVID-19. Finally, strategies for using information in a beneficial manner should be investigated (e.g., offering psychoeducation on coping skills to manage patient expectations; Evers et al., 2021; Manai et al., 2019) .

In summary, the current study demonstrates that information regarding COVID-19 may have clinical implications and, in certain cases, can increase subjective neurological complains due to the deleterious effects of diagnosis threat.

Moreover, highly suggestible recovered COVID-19 patients may be particularly vulnerable to such an effect. It is advised that such factors be considered when Diagnosis threat and post COVID-19 cognitive complaints 15 15 assessing cognitive complaints of post COVID-19 patients (see, also, Evers et al., 2021) . However, the current study's findings should be viewed as preliminary and await further research. "My concern is that we currently have at least 10 million recovering patients who could be suffering from cognitive deficits that will impair their ability to work and perform day-to-day activities" said Adrian Owen, a neurology expert from the University of Western Ontario, to the Reuters news agency.

Concerns regarding these findings were also noted by the brain institute of the University College of London. Researcher Ross Patterson, one of the researchers which published the warning regarding the appearance of ADEM inflammation, says that "In the past, one adult was diagnosed with it circa ones a month. It is a disease that is common among children. But since the appearance of COVID-19, we have had a case like this at least once a week."

"In fact, COVID-19 is a new disease, and we don't know enough about its effects on the brain." two swab tests ten days after being diagnosed. The same procedure will apply for dialysis patients. 

What Should Clinicians Tell Patients about Placebo and Nocebo Effects?

Cognitive and mental health changes and their vulnerability factors related to COVID-19 lockdown in Italy

Influence of diagnosis threat and illness cognitions on the cognitive performance of people with acquired brain injury

Normality tests for statistical analysis: A guide for nonstatisticians

Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?

Historical background to suggestibility: How interrogative suggestibility differs from other types of suggestibility. Personality and Individual 19): the epidemic and the challenges

Structural and Functional Hippocampal Changes in Subjective Cognitive Decline From the Community

Increased levels of plasma amyloid-beta are related to cortical thinning and cognitive decline in cognitively normal elderly subjects

How to prevent, minimize, or extinguish nocebo effects in pain: a narrative review on mechanisms, predictors, and interventions

Real-time tracking of self-reported symptoms to predict potential COVID-19

Symptom Self-Reports Are Susceptible to Misinformation

Rapid assessment of psychological and epidemiological correlates of COVID-19 concern, financial strain, and health-related behavior change in a large online sample

The iatrogenic power of labeling medically unexplained symptoms: A critical review and meta-analysis of "diagnosis threat" in mild head injury

Suggestibility as a predictor of response to antidepressants: A preliminary prospective trial

Fighting COVID-19 misinformation on social media: Experimental evidence for a scalable accuracynudge intervention

A Multidimensional Approach to Post-concussion Symptoms in Mild Traumatic Brain Injury

A new application of social impact in social media for overcoming fake news in health

Relationship between trait suggestibility and eating-related behaviors in overweight and obesity. Eating Behaviors

The cognitive consequences of the COVID-19 epidemic: collateral damage? Brain Commun

The being a patient effect: negative expectations based on group labeling and corresponding treatment affect patient

Diagnosis Threat": The effect of negative expectations on cognitive performance in head injury

Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations

Prevalence of post-concussion-like symptoms in the general population in Italy, The Netherlands and the United Kingdom

Post-COVID 19 Neurological Syndrome (PCNS); a novel syndrome with challenges for the global neurology community

Self-Reported Cognitive Failures: Competing Measurement Models and Self-Report Correlates